The second Drug Utilization Review (DUR) system was implemented from November 2 on a trial basis, but it could not be properly conducted as planned as the government raised the H1N1 flu alert to its highest level, pledging all-out efforts against the further spread of the disease throughout the nation.
Nevertheless, Chung Kwang-eun, chairman of Cheju Pharmaceutical Association, said that the...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.